Published in Am J Gastroenterol on March 14, 2017
Editorial: Functional Dyspepsia Treatment: Trials and Tribulations of Targeted Strategies. Am J Gastroenterol (2017) 0.75
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Functional gastroduodenal disorders. Gastroenterology (2006) 8.51
Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Gastroenterology (2015) 3.45
Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology (1996) 3.22
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology (2002) 2.52
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry (2006) 2.29
G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology (2004) 2.24
Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions. Int J Neuropsychopharmacol (2002) 2.03
Candidate genotypes associated with functional dyspepsia. Neurogastroenterol Motil (2008) 1.86
Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol (2001) 1.62
Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol (2013) 1.42
Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci (2001) 1.40
Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol (1998) 1.37
Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology (Berl) (2003) 1.32
Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol (2001) 1.16
G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation. Circ Res (1999) 1.15
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials (2012) 1.10
Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol (1999) 1.07
Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport (2000) 1.06
Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther (2010) 1.05
The G-protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome-like dyspepsia. BMC Med Genet (2010) 1.04
Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther (2003) 1.04
A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin. Scand J Gastroenterol (1996) 0.99
Functional dyspepsia and gastroparesis: one disease or two? Am J Gastroenterol (2012) 0.95
Genetic factors for functional dyspepsia. J Gastroenterol Hepatol (2011) 0.94
Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther (2003) 0.89
Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an Australian cohort. J Gastroenterol Hepatol (2014) 0.89
Hypothesis driven research and molecular mechanisms in functional dyspepsia: the beginning of a beautiful friendship in research and practice? Am J Gastroenterol (2006) 0.88
Serotonin transporter gene polymorphism may be associated with functional dyspepsia in a Japanese population. BMC Med Genet (2011) 0.87
Candidate genes for antidepressant response to selective serotonin reuptake inhibitors. Neuropsychiatr Dis Treat (2005) 0.86
Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications. Curr Psychiatry Rep (2015) 0.84
Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. J Gastroenterol (2015) 0.83
Antimuscarinic and other receptor-blocking properties of antidepressants. Mayo Clin Proc (1983) 0.82
Systematic review with meta-analysis: post-infectious functional dyspepsia. Aliment Pharmacol Ther (2014) 0.82
Association analysis of a functional G protein beta3 subunit gene polymorphism (C825T) in mood disorders. Neuropsychobiology (2001) 0.81
Serotonin receptor 3A polymorphism c.-42C > T is associated with severe dyspepsia. BMC Med Genet (2011) 0.81
Variation in GNB3 predicts response and adverse reactions to antidepressants. J Psychopharmacol (2010) 0.80
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders. Pharmacogenomics (2015) 0.76
G protein β3 subunit polymorphism and long-term prognosis of functional dyspepsia. Gut Liver (2014) 0.76
AJG series: molecular biology for clinicians. Am J Gastroenterol (2009) 0.75
Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Gastroenterology (2015) 3.45